Sorry, this entry is only available in Ukrainian and Russian.
Вас может заинтересовать:
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
WEB only
With the acquisition of the majority shareholding of Nicomac by Mangini, a new entity is born today in Italy, among the most important in Europe in the cleanroom and OSD…